Close
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Menu
GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us
Facebook
Search
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Old FDA Advisories
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
Menu
Home
About FDA
Transparency
Issuances
Advisories
Administrative Order
Executive Order
FDA Circular
FDA Memorandum
Memorandum Circular
Republic Act
Old Issuances
Old FDA Advisories
Services
eServices
ePortal
ePortal2
Doctrack
RRDportal
COVID-19 Vaccine (Vero Cell), Inactivated [COVID-19 Vaccine Sinopharm]
COVID-19 Vaccine Sinopharm (Beijing)
On 10 September 2021, the Food and Drug Administration (FDA)
issued authorization granting the Department of Health the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Beijing)].
Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click
here
.
COVID-19 Vaccine Sinopharm (Wuhan)
On 19 August 2021, the Food and Drug Administration (FDA)
issued authorization granting 2 World Traders Inc. the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Wuhan)].
Product Information
English
Further, on 14 October 2021, the Food and Drug Administration (FDA)
issued authorization granting Aisini International Trading the emergency use approval of COVID-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (COVIGEM)].
Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click
here
.
COVID-19 Vaccine Sinopharm (Hayat-Vax)
On 07 October 2021, the Food and Drug Administration (FDA)
issued authorization (amended on 14 October 2021) granting Southmed Pharma Corporation the emergency use approval of Covid-19 Vaccine (VeroCell), Inactivated [COVID-19 Vaccine Sinopharm (Hayat-Vax)].
Product Information
English
Information on the safety of COVID-19 Vaccine Sinopharm is discussed in their comprehensive Risk Management Plan.
For more information on reporting side effects, click
here
.
Shares